Please login to the form below

Not currently logged in


This page shows the latest Gazyvo news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Imbruvica and Gazyvo approved in first non-chemo CLL use Imbruvica and Gazyvo approved in first non-chemo CLL use

    Further boost for blockbuster leukaemia drug. B lockbuster leukaemia drug Imbruvica has extended its reach again, gaining FDA approval for combination use with Gazyvo in first-line use in chronic lymphocytic ... The approval is also good news for Roche

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...